Co-trimoxazole prophylaxis: the debates continue

Lancet HIV. 2015 Apr;2(4):e118-9. doi: 10.1016/S2352-3018(15)00019-3. Epub 2015 Mar 3.

Authors

Motasim Badri¹, Salah Moghraby²

Affiliations

¹ King Saud bin Abdulaziz University for Health Sciences, Ministry of National Guard Health Affairs, Riyadh 11481, Kingdom of Saudi Arabia. Electronic address: motasimb@hotmail.com.
² King Saud bin Abdulaziz University for Health Sciences, Ministry of National Guard Health Affairs, Riyadh 11481, Kingdom of Saudi Arabia.

PMID: 26424669
DOI: 10.1016/S2352-3018(15)00019-3

No abstract available

Publication types

Comment

MeSH terms

AIDS-Related Opportunistic Infections / drug therapy*
Anti-Infective Agents / therapeutic use
Humans
Trimethoprim, Sulfamethoxazole Drug Combination / therapeutic use*

Substances

Anti-Infective Agents
Trimethoprim, Sulfamethoxazole Drug Combination